An Iowa State University professor has assembled a team of university, medical school, research hospital, national laboratory and industry researchers to design nanovaccines using a $4.5 million grant from the university's Presidential Initiative for Interdisciplinary Research. An article on the university's news service said that the nanovaccines are designed to target diseases such as tuberculosis, malaria, biodefense pathogens and cancer. Nanovaccines are based on tiny particles that can send pathogen-like signals to immune cells, and are easier to produce and store than current vaccines. The research is being led by Balaji Narasimhan, Iowa State's Vlasta Klima Balloun Professor of Chemical and Biological Engineering. "This is truly one of the dream teams working on vaccine research anywhere in the world," Narasimhan said in the ISU article.